Unknown

Dataset Information

0

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant.

ABSTRACT: The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outcompeted previously prevalent variants and become a dominant strain worldwide. We report the structure, function, and antigenicity of its full-length spike (S) trimer as well as those of the Gamma and Kappa variants, and compare their characteristics with the G614, Alpha, and Beta variants. Delta S can fuse membranes more efficiently at low levels of cellular receptor angiotensin converting enzyme 2 (ACE2), and its pseudotyped viruses infect target cells substantially faster than the other five variants, possibly accounting for its heightened transmissibility. Each variant shows different rearrangement of the antigenic surface of the amino-terminal domain of the S protein but only makes produces changes in the receptor binding domain (RBD), making the RBD a better target for therapeutic antibodies.

SUBMITTER: Zhang J 

PROVIDER: S-EPMC10763652 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outcompeted previously prevalent variants and become a dominant strain worldwide. We report the structure, function, and antigenicity of its full-length spike (S) trimer as well as those of the Gamma and Kappa variants, and compare their characteristics with the G614, Alpha, and Beta variants. Delta S can fuse membranes more efficiently at low levels of cellular receptor angiotensin converting enzyme 2 (ACE2),  ...[more]

Similar Datasets

Unknown SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
| S-EPMC8566220 | biostudies-literature
Unknown Spike protein of SARS-CoV-2 Omicron variant: An <i>in-silico</i> study evaluating spike interactions and immune evasion.
| S-EPMC9746896 | biostudies-literature
Unknown In situ architecture and membrane fusion of SARS-CoV-2 Delta variant.
| S-EPMC10160983 | biostudies-literature
Unknown SARS-CoV-2 spike protein S:D614G + S:A222V variant
| EMPIAR-10891 | biostudies-other
Unknown Immune Evasion, Cell-Cell Fusion, and Spike Stability of the SARS-CoV-2 XEC Variant: Role of Glycosylation Mutations at the N-terminal Domain.
| S-EPMC11601353 | biostudies-literature
Unknown Host Cell Membrane Capture by the SARS-CoV-2 Spike Protein Fusion Intermediate.
| S-EPMC10255576 | biostudies-literature
Unknown SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex.
| S-EPMC9799367 | biostudies-literature
Unknown Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3.
| S-EPMC10606793 | biostudies-literature
Unknown Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity.
| S-EPMC8604694 | biostudies-literature
Unknown Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants.
| S-EPMC9229035 | biostudies-literature